Femasys Inc
NASDAQ:FEMY
Femasys Inc
NASDAQ:FEMY
Price:
1.05 USD
-5.41%
Market Closed
Updated:
Jun 7, 2024
Femasys Inc
Additional Paid In Capital
|
Femasys Inc
Additional Paid In Capital Peer Comparison
Comparables:
BSX
SYK
ABT
ISRG
SWAV
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Femasys Inc
NASDAQ:FEMY
|
Additional Paid In Capital
$124m
|
CAGR 3-Years
76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Stryker Corp
NYSE:SYK
|
Additional Paid In Capital
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Additional Paid In Capital
$8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Additional Paid In Capital
$586m
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
See Also
What is Femasys Inc's Additional Paid In Capital?
Additional Paid In Capital
124m
USD
124m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Additional Paid In Capital amounts to 124m USD.
What is Femasys Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
76%
76%
Over the last year, the Additional Paid In Capital growth was 14%. The average annual Additional Paid In Capital growth rates for Femasys Inc have been 76% over the past three years .
You don't have any saved screeners yet
